Drug Profile
Research programme: anticancer therapeutics - AxCell Biosciences
Latest Information Update: 22 Jan 2008
Price :
$50
*
At a glance
- Originator AxCell Biosciences; Thomas Jefferson University
- Class Small molecules
- Mechanism of Action Signal transduction pathway modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 07 Mar 2002 Preclinical trials in Cancer in USA (unspecified route)